- Home
- PNR vs HOLX Comparison
PNR vs HOLX Comparison
Compare PNR & HOLX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PNR
- HOLX
- Stock Information
- Founded
- PNR 1966
- HOLX 1985
- Country
- PNR United Kingdom
- HOLX United States
- Employees
- PNR N/A
- HOLX N/A
- Industry
- PNR Industrial Machinery/Components
- HOLX Medical Electronics
- Sector
- PNR Industrials
- HOLX Health Care
- Exchange
- PNR Nasdaq
- HOLX Nasdaq
- Market Cap
- PNR 17.4B
- HOLX 16.5B
- IPO Year
- PNR N/A
- HOLX 1990
- Fundamental
- Price
- PNR $104.94
- HOLX $74.35
- Analyst Decision
- PNR Buy
- HOLX Hold
- Analyst Count
- PNR 14
- HOLX 15
- Target Price
- PNR $119.57
- HOLX $79.64
- AVG Volume (30 Days)
- PNR 1.2M
- HOLX 3.6M
- Earning Date
- PNR 10-21-2025
- HOLX 11-03-2025
- Dividend Yield
- PNR 0.99%
- HOLX N/A
- EPS Growth
- PNR N/A
- HOLX N/A
- EPS
- PNR 3.93
- HOLX 2.49
- Revenue
- PNR $4,128,399,999.00
- HOLX $4,100,500,000.00
- Revenue This Year
- PNR $2.97
- HOLX $6.23
- Revenue Next Year
- PNR $4.64
- HOLX $5.37
- P/E Ratio
- PNR $26.66
- HOLX $29.86
- Revenue Growth
- PNR 0.83
- HOLX 1.74
- 52 Week Low
- PNR $74.25
- HOLX $51.90
- 52 Week High
- PNR $113.95
- HOLX $80.31
- Technical
- Relative Strength Index (RSI)
- PNR 44.64
- HOLX 67.73
- Support Level
- PNR $101.38
- HOLX $74.09
- Resistance Level
- PNR $109.89
- HOLX $74.66
- Average True Range (ATR)
- PNR 2.41
- HOLX 0.22
- MACD
- PNR -0.41
- HOLX -0.25
- Stochastic Oscillator
- PNR 43.29
- HOLX 57.86
About PNR Pentair plc.
Pentair is a global leader in the water treatment industry, with 10,000 employees and a presence in 25 countries. Its business is organized into three segments: pool, water technologies, and flow. The company offers a wide range of water solutions, including energy-efficient swimming pool equipment, filtration solutions, and commercial and industrial pumps. Pentair generated approximately $4.1 billion in revenue in 2024.
About HOLX Hologic Inc.
Hologic manufactures proprietary products for the healthcare needs of women. The company operates in four segments: diagnostics (44% of total sales), breast health (38%), surgical (16%), and skeletal health (2%). While the company traditionally focused on breast health, the acquisition of Gen-Probe put greater emphasis on commercial diagnostics. The United States accounts for the largest portion of the firm's revenue (69%), followed by Europe (20%), Asia (8%), and other international markets (3%). Hologic is headquartered in Bedford, Massachusetts.